Metraipolis › archive › dc_1df8ab4d54ef

Real-world effectiveness and safety of CDK4/6i in elderly and BIPOC patients with HR+/HER2- advanced/metastatic breast cancer: an updated systematic… — Europe PMC PMID:40896422

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40896422
DOI
10.3389/fonc.2025.1577075
License (as archived)
solo-consultazione
Archived
2026-11-10T14:26:57.709Z
SHA-256 of the archived text
3e75a47e35ef7398a855439e01e2713754d4784836a606ac6073a24b053bf924
Stable URL of this page
https://metraipolis.com/documento/dc_1df8ab4d54ef

How to cite

Real-world effectiveness and safety of CDK4/6i in elderly and BIPOC patients with HR+/HER2- advanced/metastatic breast cancer: an updated systematic… — Europe PMC PMID:40896422 — Europe PMC (en), https://europepmc.org/article/MED/40896422 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1df8ab4d54ef (Metraipolis archive dc_1df8ab4d54ef, sha256 3e75a47e35ef7398a855439e01e2713754d4784836a606ac6073a24b053bf924)
BibTeX
@misc{dc1df8ab4d54ef,
  title = {Real-world effectiveness and safety of CDK4/6i in elderly and BIPOC patients with HR+/HER2- advanced/metastatic breast cancer: an updated systematic… — Europe PMC PMID:40896422},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40896422},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1df8ab4d54ef; sha256 3e75a47e35ef7398a855439e01e2713754d4784836a606ac6073a24b053bf924},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40896422. Agents can read the archived copy with the MCP tool read_document.